Efficacy of teclistamab in patients (pts) with heavily pretreated, relapsed/refractory multiple myeloma (RRMM), including those refractory to penta RRMM and BCMA (B-cell maturation antigen) directed therapy (BDT)

被引：0
|
作者：
Venkatesh, Priyanka
Atrash, Shebli
Paul, Barry
Alkharabsheh, Omar
Afrough, Aimaz
Mahmoudjafari, Zahra
Mushtaq, Muhammad Umair
Hashmi, Hamza
Davis, James A.
Abdallah, Al-Ola A.
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS USA
[2] Levine Canc Inst, Charlotte, NC USA
[3] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA
[4] UT Southwestern Med Ctr, Dallas, TX USA
[5] Univ Kansas, Ctr Canc, Westwood, KS USA
[6] Med Univ South Carolina, Charleston, SC USA
[7] Univ Kansas, US Myeloma Res Innovat Res Collaborat USMIRC, Med Ctr, Westwood, KS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naive in Penta-Relapsed Refractory Multiple Myeloma (RRMM)
    Mammadzadeh, Aytaj
    Peng, Fulei
    Atrash, Shebli
    Hashmi, Hamza
    Mohan, Meera
    Alkharabsheh, Omar
    Afrough, Aimaz
    Cui, Wei
    Mahmoudjafari, Zahra
    Abdallah, Al-Ola
    BLOOD, 2022, 140 : 4277 - 4278
  • [2] Metronomic therapy for heavily pretreated relapsed/refractory multiple myeloma (RRMM).
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Mitchell, Alan
    Keller, Jason
    Heuck, Christoph Johann
    Waheed, Sarah
    Usmani, Saad Zafar
    Nair, Bijay
    Van Rhee, Frits
    Medlin, Stephen Charles
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Efficacy and safety of elranatamab in pts with relapsed/ refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: a pooled analysis from MagnetisMM studies
    Raab, M. S.
    Hanel, M.
    Nooka, A. K.
    Lesokhin, A. M.
    Mohty, M.
    Niesvizky, R.
    Maisel, C.
    Arnulf, B.
    Larson, S. M.
    Varshavsky-Yanovsky, A. N.
    Leleu, X.
    Karlin, L.
    Vesole, D. H.
    Bahlis, N. J.
    de larrea, Fernandez C.
    Raje, N.
    Leip, E.
    Conte, U.
    Elmeliegy, M.
    Viqueira, A.
    Manier, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 232 - 232
  • [4] Pooled Analysis of MagnetisMM Studies: Efficacy and Safety of Elranatamab in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Previously Exposed to B-cell Maturation Antigen (BCMA)-Directed Therapies
    Ajay, Nooka K.
    Alexander, Lesokhin M.
    Mahamad, Mohty
    Ruben, Niesvizky
    Christopher, Maisel
    Bertrand, Arnulf
    Sarah, Larson M.
    Nina, Asya Varshavsky-Yanovsky
    Xavier, Leleu
    Lionel, Karlin
    David, Vesole H.
    Nizar, Bahlis J.
    de Larrea Carlos, Fernandez
    Noopur, Raje
    Eric, Leip
    Umbarto, Conte
    Mohamed, Elmeliegy
    Andrea, Viqueira
    Saloman, Manier
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S27 - S28
  • [5] Efficacy and Safety of Elranatamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) and Prior B-Cell Maturation Antigen (BCMA)-Directed Therapies: Pooled Analysis From MagnetisMM Studies
    Nooka, Ajay K.
    Lesokhin, Alexander M.
    Mohty, Mohamad
    Niesvizky, Ruben
    Maisel, Christopher
    Arnulf, Bertrand
    Larson, Sarah M.
    Varshavsky-Yanovsky, Asya Nina
    Leleu, Xavier
    Karlin, Lionel
    Vesole, David H.
    Bahlis, Nizar J.
    Fernandez de Larrea, Carlos
    Raje, Noopur
    Leip, Eric
    Conte, Umberto
    Elmeliegy, Mohamed
    Viqueira, Andrea
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S496 - S497
  • [6] Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM)
    Garfall, Alfred L.
    Usmani, Saad Z.
    Mateos, Maria-Victoria
    Nahi, Hareth
    van de Donk, Niels W. C. J.
    San-Miguel, Jesus F.
    Rocafiguera, Albert Oriol
    Rosinol, Laura
    Chari, Ajai
    Bhutani, Manisha
    Pei, Lixia
    Verona, Raluca
    Girgis, Suzette
    Stephenson, Tara
    Goldberg, Jenna D.
    Banerjee, Arnob
    Krishnan, Amrita
    BLOOD, 2020, 136
  • [7] MELFLUFEN THERAPY FOR HEAVILY PRETREATED RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS REFRACTORY TO DARATUMUMAB AND/OR POMALIDOMIDE: EARLY EFFICACY DATA (HORIZON)
    Mateos, M., V
    Oriol Rocafiguera, A.
    Rodriguez-Otero, P.
    Blade, J.
    Larocca, A.
    Moreb, S. J.
    Cavo, M.
    Mazumder, A.
    Alegre, A.
    Hassoun, H.
    Maisel, C.
    Paner, A.
    Gabrail, N.
    Halka, K.
    Zonder, J.
    Ocio, E.
    Byrne, C.
    Harmenberg, J.
    Lindberg, J.
    Nordstrom, E.
    Thuresson, S.
    Richardson, G. P.
    HAEMATOLOGICA, 2018, 103 : 32 - 32
  • [8] Efficacy and safety of teclistamab (tec), a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients (pts) with relapsed/refractory multiple myeloma (RRMM) after exposure to other BCMA-targeted agents.
    Touzeau, Cyrille
    Krishnan, Amrita Y.
    Moreau, Philippe
    Perrot, Aurore
    Usmani, Saad Zafar
    Manier, Salomon
    Cavo, Michele
    Martinez-Chamorro, Carmen
    Nooka, Ajay K.
    Martin, Thomas G.
    Karlin, Lionel
    Leleu, Xavier
    Bahlis, Nizar J.
    Besemer, Britta
    Pei, Lixia
    Verona, Raluca
    Girgis, Suzette
    Uhlar, Clarissa
    Kobos, Rachel
    Garfall, Alfred L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies.
    Nooka, Ajay K.
    Lesokhin, Alexander M.
    Mohty, Mohamad
    Niesvizky, Ruben
    Maisel, Christopher
    Arnulf, Bertrand
    Larson, Sarah Marie
    Yanovsky, Asya Varshavsky
    Leleu, Xavier P.
    Karlin, Lionel
    Vesole, David H.
    Bahlis, Nizar J.
    de Larrea, Carlos Fernandez
    Raje, Noopur S.
    Leip, Eric
    Conte, Umberto
    Elmeliegy, Mohamed
    Viqueira, Andrea
    Manier, Salomon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Correlative Analyses from MajesTEC-1
    Cortes-Selva, Diana
    Casneuf, Tineke
    Vishwamitra, Deeksha
    Stein, Sarah
    Perova, Tatiana
    Skerget, Sheri
    Ramos, Elena
    van Steenbergen, Laure
    De Maeyer, Dries
    Boominathan, Rengasamy
    Lau, Onsay
    Davis, Cuc
    Banerjee, Arnob
    Stephenson, Tara
    Uhlar, Clarissa M.
    Kobos, Rachel
    Goldberg, Jenna D.
    Pei, Lixia
    Trancucci, Danielle
    Girgis, Suzette
    Lin, Shun Xin Wang
    Wu, Liviawati S.
    Moreau, Philippe
    Usmani, Saad
    Bahlis, Nizar Jacques
    Van de Donk, Niels W. C. J.
    Verona, Raluca
    BLOOD, 2022, 140
12345